LOCUS       NP_058836                446 aa                     ROD 10-AUG-2014
DEFINITION  D(3) dopamine receptor [Rattus norvegicus].
ACCESSION   NP_058836
VERSION     NP_058836.1  GI:8393271
KEYWORDS    RefSeq.
SOURCE      Rattus norvegicus (Norway rat)
  ORGANISM  Rattus norvegicus
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia;
            Sciurognathi; Muroidea; Muridae; Murinae; Rattus.
REFERENCE   1  (residues 1 to 446)
  AUTHORS   Avalos-Fuentes A, Loya-Lopez S, Flores-Perez A, Recillas-Morales S,
            Cortes H, Paz-Bermudez F, Aceves J, Erlij D and Floran B.
  TITLE     Presynaptic CaMKIIalpha modulates dopamine D3 receptor activation in
            striatonigral terminals of the rat brain in a Ca(2)(+) dependent
            manner
  JOURNAL   Neuropharmacology 71, 273-281 (2013)
   PUBMED   23602989
  REMARK    GeneRIF: Data suggest that Camk2a (calcium-calmodulin-dependent
            protein kinase II, alpha) regulates Drd3 (dopamine receptor D3)
            activation in presynaptic terminals of substantia nigra via calcium
            signaling.
REFERENCE   2  (residues 1 to 446)
  AUTHORS   Moreno M, Economidou D, Mar AC, Lopez-Granero C, Caprioli D,
            Theobald DE, Fernando A, Newman AH, Robbins TW and Dalley JW.
  TITLE     Divergent effects of D(2)/(3) receptor activation in the nucleus
            accumbens core and shell on impulsivity and locomotor activity in
            high and low impulsive rats
  JOURNAL   Psychopharmacology (Berl.) 228 (1), 19-30 (2013)
   PUBMED   23407782
  REMARK    GeneRIF: The findings indicate that impulsivity and hyperactivity
            are separately regulated by core and shell sub-regions of the
            nucleus accumbens and that high impulsive rats show an enhanced
            response to D2/3 receptor activation in these regions
REFERENCE   3  (residues 1 to 446)
  AUTHORS   Caprioli D, Hong YT, Sawiak SJ, Ferrari V, Williamson DJ, Jupp B,
            Adrian Carpenter T, Aigbirhio FI, Everitt BJ, Robbins TW, Fryer TD
            and Dalley JW.
  TITLE     Baseline-dependent effects of cocaine pre-exposure on impulsivity
            and D2/3 receptor availability in the rat striatum: possible
            relevance to the attention-deficit hyperactivity syndrome
  JOURNAL   Neuropsychopharmacology 38 (8), 1460-1471 (2013)
   PUBMED   23399948
  REMARK    GeneRIF: Dopamine D3 (and D2) availability was inversely related to
            baseline D2/3 receptor availability in the ventral striatum of
            high-impulsive rats.
REFERENCE   4  (residues 1 to 446)
  AUTHORS   Ruiz-Salinas I, Gonzalez-Hernandez A, Manrique-Maldonado G,
            Marichal-Cancino BA, Altamirano-Espinoza AH and Villalon CM.
  TITLE     Predominant role of the dopamine D3 receptor subtype for mediating
            the quinpirole-induced inhibition of the vasopressor sympathetic
            outflow in pithed rats
  JOURNAL   Naunyn Schmiedebergs Arch. Pharmacol. 386 (5), 393-403 (2013)
   PUBMED   23420100
  REMARK    GeneRIF: Inhibition of vasopressor sympathetic quinpirole-induced
            outflow in pithed rats is mediated predominantly by dopamine D3
            receptors.
REFERENCE   5  (residues 1 to 446)
  AUTHORS   Scardochio T and Clarke PB.
  TITLE     Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor
            subtype-selective agonists and antagonists in adult rats
  JOURNAL   Psychopharmacology (Berl.) 226 (3), 589-600 (2013)
   PUBMED   23192317
  REMARK    GeneRIF: Dopaminergic transmission through D1, D2, and D3 receptors
            appears necessary for spontaneous ultrasonic calling in rats
REFERENCE   6  (residues 1 to 446)
  AUTHORS   Crocq MA, Mant R, Asherson P, Williams J, Hode Y, Mayerova A,
            Collier D, Lannfelt L, Sokoloff P and Schwartz JC.
  CONSRTM   et al
  TITLE     Association between schizophrenia and homozygosity at the dopamine
            D3 receptor gene
  JOURNAL   J. Med. Genet. 29 (12), 858-860 (1992)
   PUBMED   1362221
REFERENCE   7  (residues 1 to 446)
  AUTHORS   Livingstone CD, Strange PG and Naylor LH.
  TITLE     Molecular modelling of D2-like dopamine receptors
  JOURNAL   Biochem. J. 287 (PT 1), 277-282 (1992)
   PUBMED   1358063
REFERENCE   8  (residues 1 to 446)
  AUTHORS   Snyder LA, Roberts JL and Sealfon SC.
  TITLE     Alternative transcripts of the rat and human dopamine D3 receptor
  JOURNAL   Biochem. Biophys. Res. Commun. 180 (2), 1031-1035 (1991)
   PUBMED   1953708
REFERENCE   9  (residues 1 to 446)
  AUTHORS   Giros B, Martres MP, Pilon C, Sokoloff P and Schwartz JC.
  TITLE     Shorter variants of the D3 dopamine receptor produced through
            various patterns of alternative splicing
  JOURNAL   Biochem. Biophys. Res. Commun. 176 (3), 1584-1592 (1991)
   PUBMED   2039532
REFERENCE   10  (residues 1 to 446)
  AUTHORS   Sokoloff P, Giros B, Martres MP, Bouthenet ML and Schwartz JC.
  TITLE     Molecular cloning and characterization of a novel dopamine receptor
            (D3) as a target for neuroleptics
  JOURNAL   Nature 347 (6289), 146-151 (1990)
   PUBMED   1975644
COMMENT     PROVISIONAL REFSEQ: This record has not yet been subject to final
            NCBI review. The reference sequence was derived from X53944.1.
            Summary: may be involved in facilitating the effects of
            antipsychotic drugs and drug treatments for Parkinson's disease
            [RGD, Feb 2006].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##Evidence-Data-START##
            Transcript exon combination :: X53944.1 [ECO:0000332]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..446
                     /strain="Sprague-Dawley"
                     /map="11q21"
                     /organism="Rattus norvegicus"
                     /chromosome="11"
                     /db_xref="taxon:10116"
     Protein         1..446
                     /note="dopaminergic receptor D3; dopamine D3 receptor"
                     /product="D(3) dopamine receptor"
                     /calculated_mol_wt="49385"
     Site            33..55
                     /note="propagated from UniProtKB/Swiss-Prot (P19020.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          44..>225
                     /note="Serpentine type 7TM GPCR chemoreceptor Srsx;
                     pfam10320"
                     /db_xref="CDD:255903"
                     /region_name="7TM_GPCR_Srsx"
     Region          52..429
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            66..88
                     /note="propagated from UniProtKB/Swiss-Prot (P19020.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            105..126
                     /note="propagated from UniProtKB/Swiss-Prot (P19020.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            150..170
                     /note="propagated from UniProtKB/Swiss-Prot (P19020.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            188..212
                     /note="propagated from UniProtKB/Swiss-Prot (P19020.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          189..196
                     /note="propagated from UniProtKB/Swiss-Prot (P19020.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist binding (By similarity)"
     Site            376..397
                     /note="propagated from UniProtKB/Swiss-Prot (P19020.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          388..396
                     /note="propagated from UniProtKB/Swiss-Prot (P19020.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist binding (By similarity)"
     Site            413..434
                     /note="propagated from UniProtKB/Swiss-Prot (P19020.1)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     CDS             1..446
                     /coded_by="NM_017140.1:82..1422"
                     /gene="Drd3"
                     /db_xref="GeneID:29238"
                     /db_xref="RGD:2521"
ORIGIN
        1 maplsqisth lnstcgaens tgvnrarpha yyalsycali laiifgnglv caavlreral
       61 qtttnylvvs lavadllvat lvmpwvvyle vtggvwnfsr iccdvfvtld vmmctasiln
      121 lcaisidryt avvmpvhyqh gtgqsscrrv almitavwvl afavscpllf gfnttgdpsi
      181 csisnpdfvi yssvvsfyvp fgvtvlvyar iyivlrqrqr kriltrqnsq cisirpgfpq
      241 qssclrlhpi rqfsirarfl sdatgqmehi edkqypqkcq dpllshlqpp spgqthgglk
      301 ryysicqdta lrhpslegga gmspvertrn slsptmapkl slevrklsng rlstslrlgp
      361 lqprgvplre kkatqmvviv lgafivcwlp fflthvlnth cqachvspel yrattwlgyv
      421 nsalnpviyt tfnvefrkaf lkilsc
//
